On February 2, 2021, Flosonics Medical announced the close of a US$14 million funding round which included participation from existing investors iGan Partners and Genesys Capital. Financing proceeds will be used for commercial launch in North America and new product development.
iGan Partners is a Toronto-based venture capital and private equity firm that invests in emerging tech companies.
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology.
Flosonics Medical is a venture-backed medical device company headquartered in Sudbury, Ontario. Flosonics Medical is focused on the intersection of wearable sensors, ultrasound, and connected devices.
Osler, Hoskin & Harcourt LLP advised iGan Partners and Genesys Capital with a team consisting of André Perey, Michael Grantmyre, Jeremy Lin and Scott Lin (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Associate, Emerging and High Growth Companies, Toronto
Partner, Emerging and High Growth Companies, Calgary
